Skip to content
Latest
Walmart, Eli Lilly join growing pushback against OKX–ICE tokenized stock plans Understanding the Various Bitcoin Per Share Metrics Moving Averages: SMA, EMA, and Crossovers Oracle Stock Forecast: ORCL Tests Its 50-Day Averages USD/RUB Forecast: Ruble Steady Near 80.5 as Oil Props Up PCE inflation accelerates to 3.6% as GDP growth beats estimates, jobless claims fall GBP/USD Forecast: Cable Eyes 1.3420 After the Fed Hold DoorDash strikes $17B deal for rival Instacart in bets on grocery delivery Walmart, Eli Lilly join growing pushback against OKX–ICE tokenized stock plans Understanding the Various Bitcoin Per Share Metrics Moving Averages: SMA, EMA, and Crossovers Oracle Stock Forecast: ORCL Tests Its 50-Day Averages USD/RUB Forecast: Ruble Steady Near 80.5 as Oil Props Up PCE inflation accelerates to 3.6% as GDP growth beats estimates, jobless claims fall GBP/USD Forecast: Cable Eyes 1.3420 After the Fed Hold DoorDash strikes $17B deal for rival Instacart in bets on grocery delivery
STOX.NEWS
In focus
BTC 73 POST 56 HOOD 35 NXTT 26 JST 24 GOOGL 20 TLDR 17 XRP 16

Lilly raises outlook for third time this year as Zepbound sales soar

MarketWatch
Image supplied by MarketWatch.
Advertisement
Demo creative for ADG7 Article top (728x90)

The GLP-1 drug continues to dominate the market for prescription weight-loss drugs in the U.S.

Related video

Advertisement
Demo creative for ADG8 Article body (336x280)

Companies named

More on this

Advertisement
Demo creative for ADG3 Footer banner (728x90)